Palmitoyl pentapeptide-4 (Matrixyl): what can it do for your skin?
Clinical review pending
What palmitoyl pentapeptide-4 in skin care products might do, what a 12-week study found and where the data on effects and tolerability are limited.
Palmitoyl pentapeptide-4 may make fine lines and wrinkles slightly less visible. The support for this comes from a controlled 12-week study in 93 women. Large independent studies and long-term data are scarce, though. The ingredient, also known as Matrixyl, is found mainly in serums and moisturizers that are applied to the skin. 1
What is palmitoyl pentapeptide-4?
Palmitoyl pentapeptide-4, or pal-KTTKS for short, is a synthetic peptide for topical skin care. Its core is made of five amino acids: lysine, threonine, threonine, lysine and serine. Their sequence gives the abbreviation KTTKS and comes from a section of the precursor of type I collagen, known as the propeptide. Attaching a palmitic acid chain produces pal-KTTKS, the form used in skin care products. 1, 2
The ingredient is sold under trade names such as Matrixyl. Serums and moisturizers containing this peptide are meant to condition and smooth the skin and soften visible signs of skin aging. That describes the intended use; how well it succeeds is something human studies have to show. 3
How does it work?
The idea behind the ingredient goes back to research on KTTKS. This fragment comes from the precursor of type I collagen. In the lab, it prompts fibroblasts, the connective tissue cells of the skin, to make type I collagen, type III collagen and fibronectin. These substances are part of the skin matrix, the skin’s supporting framework. The researchers suspected a feedback mechanism: a fragment released during collagen processing might signal cells to produce more components of this matrix. 2
Unmodified KTTKS on its own is poorly suited to topical use. That is why pal-KTTKS was developed by adding a palmitic acid group. It is intended to stimulate collagen production and so make skin look firmer and fine lines and wrinkles less visible. The lab finding alone, however, does not show that a product applied to the skin achieves this cosmetic effect. 1
Is palmitoyl pentapeptide-4 FDA-approved?
No. Such approval is generally not foreseen for cosmetic ingredients anyway. The US Food and Drug Administration (FDA) does not approve cosmetics or most of their ingredients before they go on sale. Rules still apply, though: products must be safe when used as intended and must be properly labeled. So the fact that a serum contains an anti-aging peptide does not mean it is “FDA-approved.” 4
Under US law, what matters is a product’s intended use. If it is meant to improve appearance, it generally counts as a cosmetic. If instead it promises to change the structure or function of the skin, the FDA can classify it as a drug and treat it accordingly if it lacks approval. That is why claims about cosmetic skin care usually refer to the skin’s appearance. 5
What is it used for?
Palmitoyl pentapeptide-4 is used almost exclusively in anti-aging products applied to the skin. It is meant to condition, smooth and soothe the skin. 3
The central clinical study looked at one specific question: does a cream containing the peptide make fine lines and wrinkles less visible on photoaged facial skin? “Photoaged” here means skin that has developed signs of aging from light exposure. 1
What does the research show?
The most important controlled evidence of a cosmetic benefit comes from one clinical study. Earlier lab work explains why KTTKS was studied for this purpose; it does not yet answer how a cream affects visible wrinkles.
| Study | Model or people studied | Result |
|---|---|---|
| Double-blind, placebo-controlled study from 2005 1 | 93 women aged 35 to 55, over 12 weeks | A moisturizer with 3 ppm pal-KTTKS improved the appearance of fine lines and wrinkles compared with placebo, a statistically significant difference. |
| Earlier lab work | Fibroblasts | The KTTKS fragment stimulates collagen production in fibroblasts. 2 |
The concentration unit ppm stands for “parts per million.” “Statistically significant” describes the statistical analysis of the difference from the placebo group. On its own, it does not tell you how noticeable the change was in everyday life.
Several limitations apply when weighing these results:
- Researchers at Procter & Gamble conducted the central study. 1
- The groups studied were small.
- Large independent studies and long-term data are scarce.
The results therefore point to a fairly modest cosmetic benefit. They do not demonstrate a pronounced effect, and it also remains open how the result holds up with longer use.
What side effects are there?
In the clinical study, participants tolerated pal-KTTKS on the skin well. 1 Still, as with other skin care ingredients, some people may experience mild redness, irritation or allergic reactions. Before regular use, it is therefore sensible to try the product on a small patch of skin first.
With the products described here, the peptide is applied to the skin, not injected. The tolerability information therefore refers to topical cosmetic use. Good tolerability during the study also does not answer every question about long-term use.